Resilience care

Resilience Care develops digital health solutions predominantly for oncology, utilizing a patient-centric mobile application and a streamlined clinical dashboard for healthcare providers. The company's platform harnesses real-world health data and advanced analytics to enable more precise care, accelerate therapeutic innovation, and empower individuals throughout their treatment journey. Key capabilities include remote monitoring, personalized follow-up, early symptom detection, and transforming data into actionable insights for improved clinical decision-making.

Céline Lazorthes and Jonathan Benhamou co-founded Resilience Care in 2021. Their entrepreneurial insight stemmed from the conviction that digital innovation could fundamentally transform healthcare delivery, making it more patient-centered, personalized, and equitable. The founders sought to bridge gaps in care and research by placing the patient experience at the core of technological development.

The company serves a diverse set of stakeholders, including patients, healthcare providers across oncology, gastroenterology, and psychiatry, as well as life sciences organizations and researchers. Resilience Care's vision is to shape the future of personalized medicine, striving for a world where every individual receives the right care at the right time. They aim to advance care pathways by leveraging continuous, high-resolution patient characterization to unlock the full potential of precision medicine, improving outcomes for all.

High-Level Overview

Resilience Care is a French healthtech startup founded in 2021 that develops a digital remote patient monitoring platform and mobile app primarily for oncology patients, with expansions into psychiatry and gastroenterology. It serves cancer patients and healthcare professionals by personalizing care pathways, managing treatment side effects, and improving quality of life through data-driven insights and therapeutic education.[2][4] Deployed in over 90 medical centers supporting more than 10,000 patients, the company raised $25 million in funding to scale internationally, riding the wave of digital health innovation for equitable, patient-centered medicine.[2][4]

The platform, a Class IIa medical device, combines a patient-facing mobile app for self-care with a professional dashboard for real-time monitoring, humanizing care and addressing gaps in traditional oncology pathways.[4] This positions Resilience Care as a growth-stage player in personalized medicine, backed by partnerships like Gustave Roussy, Europe's leading cancer center.[2][4]

Origin Story

Resilience Care was founded in February 2021 in Paris by Céline Lazorthes and Jonathan Benhamou, co-founders and co-CEOs, emerging from a partnership with Gustave Roussy to tackle inequities in cancer care access.[2][4] The idea stemmed from urgency around geography and inequality limiting quality care, starting with oncology remote monitoring to personalize and humanize patient journeys.[2][4]

Early traction came quickly: by the funding announcement, it was live in over 90 centers with 10,000+ patients, validating the model through real-world deployment and positive clinical impacts.[4] This clinician-backed origin—rooted in a top cancer institute—provided immediate credibility and momentum for expansion beyond oncology.[2]

Core Differentiators

• Patient-Centric Digital Platform: Combines a mobile app for side-effect management and self-care with a Class IIa remote monitoring dashboard, enabling precise, real-time interventions unlike fragmented legacy systems.[2][4]
• Holistic Care Personalization: Focuses on therapeutic education and supportive care, improving quality of life by integrating data across the care pathway, initially validated in oncology with Gustave Roussy.[2][4]
• Proven Scale and Partnerships: Supports 10,000+ patients across 90+ centers; $25M funding from Cathay Innovation accelerates international growth, emphasizing accessibility for all.[4]
• Core Values-Driven Approach: Guided by trust (empowering healers and patients), excellence (clinical credibility), and humility (collaborative mission), fostering strong ecosystem ties.[2]

Role in the Broader Tech Landscape

Resilience Care capitalizes on the remote patient monitoring (RPM) trend, accelerated by post-COVID digital health adoption and demand for personalized medicine amid rising chronic disease burdens like cancer.[2][4] Timing aligns with regulatory support for Class IIa devices and AI/data integration in healthcare, making scalable RPM viable as hospitals face staffing shortages and care inequities.[4]

Market forces favor it: Europe's oncology market grows with aging populations, while funding (e.g., $25M round) reflects investor bets on healthtech amid €2.5B+ AUM firms like Cathay Innovation targeting cross-border scale.[4] It influences the ecosystem by partnering with elite centers like Gustave Roussy, setting standards for patient-empowered care and bridging clinical research with real-world deployment.[2][4]

Quick Take & Future Outlook

Resilience Care is poised for aggressive expansion post-$25M raise, targeting international markets in oncology, psychiatry, and gastroenterology while deepening RPM integrations.[4] Trends like AI-enhanced personalization and value-based care will propel growth, potentially tripling patient reach as remote solutions become standard.

Its influence may evolve from niche oncology innovator to broad personalized medicine leader, challenging siloed care models—ultimately making equitable, tech-driven health accessible beyond privilege, as envisioned from its founding urgency.[2]